Aon's Latest GLP-1 Research Reveals Long-Term Employer Cost Savings and Significant Reductions in Cancer Risk for Women

Aon plc (NYSE: AON), a leading global professional services firm, today released updated findings from its multi-year study ...
Crain's Chicago Business

Long term, GLP-1s offer employers dramatic cost savings and benefits, Aon says

"Our research demonstrates the power of GLP-1 therapies to transform health outcomes, with especially promising results for ...
Nasdaq

Aon: U.S. Employer Health Care Costs Expected to Rise 9.5 Percent in 2026

CHICAGO, Sept. 10, 2025 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm, revealed today that U.S. employer health care costs are projected to rise 9.5 percent* in 2026 ...
Forbes

Weight Loss Drugs Like Ozempic Add More Than $300 Per Worker To Employers’ Health Costs

Weight loss prescriptions Wegovy, Rybelsus and Saxenda—along with diabetes drug Ozempic, often prescribed off label for weight loss—are driving health costs for employers up by more than $300 per ...
CNBC

GLP-1s can help employers lower medical costs in 2 years, new study finds

Aon researchers found that within two years, improved health outcomes for patients who were taking GLP-1 drugs lowers the growth rate of medical care costs. Aon looked at medical claims data for ...
KXAN

Aon Unveils First Workforce-Focused Analysis on GLP-1s: Medications and Holistic Support Can Transform Workforce Health and Bend the Cost Curve

Firm also sets new standard in employee health by combining GLP-1 medications and holistic support to drive adherence and sustainable outcomes for Aon's U.S. colleagues in collaboration with eMed ...
Becker's Hospital Review

Long-term GLP-1 use trims medical cost growth: Aon

Long-term GLP-1 use slows medical cost growth, according to findings published Jan. 13 from professional services firm Aon. The firm analyzed 192,000 GLP-1 users from July 2022 to March 2025, ...